Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoping Yang

Showing results (211-220 of 229) with videos related to

Pageof 23
Sort By:
Frontiers in Pharmacology|January 6, 2022
Causality Evaluation of Drug-Induced Liver Injury in Newborns and Children in the Intensive Care Unit Using the Updated Roussel Uclaf Causality Assessment MethodLing Ye, Zeying Feng, Longjian Huang, et al.
Journal of the American Chemical Society|February 6, 2023
Coordination-Driven Self-Assembly Strategy-Activated Cu Single-Atom Nanozymes for Catalytic Tumor-Specific TherapyJie Zhou, Deting Xu, Gan Tian, et al.
Expert Opinion on Investigational Drugs|June 8, 2026
Safety, tolerability, and pharmacokinetics of HL-300, a novel topical Pan-JAK inhibitor, in healthy Chinese adults: a first-in-human, randomized, double-blind, placebo-controlled phase I trialHui Qiu, Xingfei Zhang, Jie Huang, et al.
Oncotarget|October 22, 2016
Genetic polymorphisms of Wnt/β-catenin pathway genes are associated with the efficacy and toxicities of radiotherapy in patients with nasopharyngeal carcinomaJingjing Yu, Yuling Huang, Lijuan Liu, et al.
Journal of Environmental Management|June 30, 2024
Co-composting of dewatered sludge and wheat straw with newly isolated Xenophilus azovorans: Carbon dynamics, humification, and driving pathwaysXuan Wu, Runyu Gao, Xiaorui Tian, et al.
Clinical and Experimental Medicine|December 2, 2025
Pharmacokinetics, safety, and tolerability of nacubactam (OP0595) after intravenous infusion: a randomized, double-blind, placebo-controlled phase I clinical trial in healthy Chinese male subjectsHui Qiu, Tingting Wu, Lei Diao, et al.
British Journal of Clinical Pharmacology|August 10, 2019
Polyethylene glycol loxenatide (PEX168) in subjects with renal impairment: A pharmacokinetic studyJianwen Wang, Jie Huang, Wei Li, et al.
Frontiers in Cardiovascular Medicine|June 1, 2022
Long Short-Term Memory Network for Development and Simulation of Warfarin Dosing Model Based on Time Series Anticoagulant DataYun Kuang, Yaxin Liu, Qi Pei, et al.
Journal of Thoracic Disease|November 13, 2025
Efficacy, pharmacokinetics, and safety of nebulized HL231 inhalation solution in patients with chronic obstructive pulmonary disease: a randomized trialQingyuan Hu, Li Zhao, Guoping Yang, et al.
American Heart Journal|June 5, 2023
Initial treatment with a single capsule containing half-dose quadruple therapy vs standard-dose dual therapy in hypertensive patients (QUADUAL): Study protocol for a randomized, blinded, crossover trialXiexiong Zhao, Ye Chen, Guoping Yang, et al.
Pageof 23

Showing results (211-220 of 229) with videos related to

Sort By:
Pageof 23
Frontiers in Pharmacology|January 6, 2022
Causality Evaluation of Drug-Induced Liver Injury in Newborns and Children in the Intensive Care Unit Using the Updated Roussel Uclaf Causality Assessment MethodLing Ye, Zeying Feng, Longjian Huang, et al.
Journal of the American Chemical Society|February 6, 2023
Coordination-Driven Self-Assembly Strategy-Activated Cu Single-Atom Nanozymes for Catalytic Tumor-Specific TherapyJie Zhou, Deting Xu, Gan Tian, et al.
Expert Opinion on Investigational Drugs|June 8, 2026
Safety, tolerability, and pharmacokinetics of HL-300, a novel topical Pan-JAK inhibitor, in healthy Chinese adults: a first-in-human, randomized, double-blind, placebo-controlled phase I trialHui Qiu, Xingfei Zhang, Jie Huang, et al.
Oncotarget|October 22, 2016
Genetic polymorphisms of Wnt/β-catenin pathway genes are associated with the efficacy and toxicities of radiotherapy in patients with nasopharyngeal carcinomaJingjing Yu, Yuling Huang, Lijuan Liu, et al.
Journal of Environmental Management|June 30, 2024
Co-composting of dewatered sludge and wheat straw with newly isolated Xenophilus azovorans: Carbon dynamics, humification, and driving pathwaysXuan Wu, Runyu Gao, Xiaorui Tian, et al.
Clinical and Experimental Medicine|December 2, 2025
Pharmacokinetics, safety, and tolerability of nacubactam (OP0595) after intravenous infusion: a randomized, double-blind, placebo-controlled phase I clinical trial in healthy Chinese male subjectsHui Qiu, Tingting Wu, Lei Diao, et al.
British Journal of Clinical Pharmacology|August 10, 2019
Polyethylene glycol loxenatide (PEX168) in subjects with renal impairment: A pharmacokinetic studyJianwen Wang, Jie Huang, Wei Li, et al.
Frontiers in Cardiovascular Medicine|June 1, 2022
Long Short-Term Memory Network for Development and Simulation of Warfarin Dosing Model Based on Time Series Anticoagulant DataYun Kuang, Yaxin Liu, Qi Pei, et al.
Journal of Thoracic Disease|November 13, 2025
Efficacy, pharmacokinetics, and safety of nebulized HL231 inhalation solution in patients with chronic obstructive pulmonary disease: a randomized trialQingyuan Hu, Li Zhao, Guoping Yang, et al.
American Heart Journal|June 5, 2023
Initial treatment with a single capsule containing half-dose quadruple therapy vs standard-dose dual therapy in hypertensive patients (QUADUAL): Study protocol for a randomized, blinded, crossover trialXiexiong Zhao, Ye Chen, Guoping Yang, et al.
Pageof 23